Wilken, L.; Stelz, S.; Agac, A.; Sutter, G.; Prajeeth, C.K.; Rimmelzwaan, G.F.
Recombinant Modified Vaccinia Virus Ankara Expressing a Glycosylation Mutant of Dengue Virus NS1 Induces Specific Antibody and T-Cell Responses in Mice. Vaccines 2023, 11, 714.
https://doi.org/10.3390/vaccines11040714
AMA Style
Wilken L, Stelz S, Agac A, Sutter G, Prajeeth CK, Rimmelzwaan GF.
Recombinant Modified Vaccinia Virus Ankara Expressing a Glycosylation Mutant of Dengue Virus NS1 Induces Specific Antibody and T-Cell Responses in Mice. Vaccines. 2023; 11(4):714.
https://doi.org/10.3390/vaccines11040714
Chicago/Turabian Style
Wilken, Lucas, Sonja Stelz, Ayse Agac, Gerd Sutter, Chittappen Kandiyil Prajeeth, and Guus F. Rimmelzwaan.
2023. "Recombinant Modified Vaccinia Virus Ankara Expressing a Glycosylation Mutant of Dengue Virus NS1 Induces Specific Antibody and T-Cell Responses in Mice" Vaccines 11, no. 4: 714.
https://doi.org/10.3390/vaccines11040714
APA Style
Wilken, L., Stelz, S., Agac, A., Sutter, G., Prajeeth, C. K., & Rimmelzwaan, G. F.
(2023). Recombinant Modified Vaccinia Virus Ankara Expressing a Glycosylation Mutant of Dengue Virus NS1 Induces Specific Antibody and T-Cell Responses in Mice. Vaccines, 11(4), 714.
https://doi.org/10.3390/vaccines11040714
